Etrolizumab for maintenance therapy in patients with moderately to severely active ulcerative colitis (LAUREL): a randomised, placebo-controlled, double-blind, phase 3 study

2021 ◽  
Author(s):  
Severine Vermeire ◽  
Peter L Lakatos ◽  
Timothy Ritter ◽  
Stephen Hanauer ◽  
Brian Bressler ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Maintenance Therapy ◽  
Active Ulcerative Colitis ◽  
Phase 3 ◽  
Double Blind

Vedolizumab Maintenance Therapy for Ulcerative Colitis: Results of GEMINI I, a Randomized, Placebo-Controlled, Double-Blind, Multicenter Phase 3 Trial

2012 ◽  
Vol 107 ◽  
pp. S609-S610 ◽  
Author(s):  
Brian Feagan ◽  
Paul Rutgeerts ◽  
Bruce Sands ◽  
William Sandborn ◽  
Jean-Frederic Colombel ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Maintenance Therapy ◽  
Phase 3 ◽  
Double Blind ◽  
Multicenter Phase

Sa1751 - A Phase 3 Study of Vedolizumab for Induction and Maintenance Therapy in Japanese Patients with Moderately to Severely Active Ulcerative Colitis

2018 ◽  
Vol 154 (6) ◽  
pp. S-380-S-381
Author(s):  
Mamoru Watanabe ◽  
Satoshi Motoya ◽  
Kenji Watanabe ◽  
Haruhiko Ogata ◽  
Takanori Kanai ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Maintenance Therapy ◽  
Japanese Patients ◽  
Active Ulcerative Colitis ◽  
Phase 3

Fr531 EFFICACY AND SAFETY OF FILGOTINIB AS MAINTENANCE THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY

2021 ◽  
Vol 160 (6) ◽  
pp. S-350
Author(s):  
Laurent Peyrin-Biroulet ◽  
Edward V. Loftus ◽  
Silvio Danese ◽  
Séverine Vermeire ◽  
William J. Sandborn ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Maintenance Therapy ◽  
Active Ulcerative Colitis ◽  
Efficacy And Safety
Sign in / Sign up

Export Citation Format

Share Document